HS Code Subheading

Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues; other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts

2937.19 Subheading
Section VI — Products of the chemical or allied industries

About HS Code 293719

This HS code serves as a residual category for polypeptide, protein, and glycoprotein hormones, their derivatives, and structural analogues, excluding somatotropin and insulin. This diverse group includes a wide range of biologically active compounds with various therapeutic applications, from stimulating red blood cell production to regulating metabolism and reproductive functions. Pharmaceutical companies, biotechnology firms, and research institutions are the primary entities involved in the international trade of these specialized hormones. Trade often involves high-value, low-volume shipments, requiring stringent quality control, cold chain management for many biologics, and compliance with complex pharmaceutical regulations. The market is characterized by ongoing research and development, leading to new therapeutic uses and a constant evolution of traded products within this category.

Products Under This Code

Erythropoietin (EPO), Glucagon, Calcitonin, Follicle-stimulating hormone (FSH), Luteinizing hormone (LH), Human chorionic gonadotropin (hCG), Parathyroid hormone (PTH)

Real World Examples

Epogen (Amgen), GlucaGen (Novo Nordisk), Miacalcin (Novartis), Gonal-f (Merck Serono), Ovidrel (Merck Serono)

Common Misclassification

This code is for 'other' polypeptide hormones and should not be used for somatotropin (293711) or insulin (293712), which have their own specific codes.

Industry

This code belongs to the Chemicals industry.

Trade Overview

Switzerland, Ireland, and the USA are significant players in the global trade of these advanced polypeptide hormones.

Frequently Asked Questions

What is HS code 293719?

HS code 293719 covers: Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues; other than somatotropin, (its derivatives and structural anaologues) and insulin and its salts. This HS code serves as a residual category for polypeptide, protein, and glycoprotein hormones, their derivatives, and structural analogues, excluding somatotropin and insulin. This diverse group includes a wide range of biologically active compounds with various therapeutic applications, from stimulating red blood cell production to regulating metabolism and reproductive functions. Pharmaceutical companies, biotechnology firms, and research institutions are the primary entities involved in the international trade of these specialized hormones. Trade often involves high-value, low-volume shipments, requiring stringent quality control, cold chain management for many biologics, and compliance with complex pharmaceutical regulations. The market is characterized by ongoing research and development, leading to new therapeutic uses and a constant evolution of traded products within this category.

What products fall under HS code 293719?

Erythropoietin (EPO), Glucagon, Calcitonin, Follicle-stimulating hormone (FSH), Luteinizing hormone (LH), Human chorionic gonadotropin (hCG), Parathyroid hormone (PTH)

What are common misclassifications for HS code 293719?

This code is for 'other' polypeptide hormones and should not be used for somatotropin (293711) or insulin (293712), which have their own specific codes.

How is HS code 293719 structured?

HS code 293719 is a 6-digit subheading under the Harmonized System. The first 2 digits (29) identify the chapter, digits 3-4 (37) identify the heading, and digits 5-6 (19) specify the subheading. This code is standardized globally by the World Customs Organization.